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Background: Thyroid carcinoma is the leading cause of death among endocrine cancers second to carcinoma of the
ovary. Now a day, the incidence of thyroid malignancy is increasing more rapidly than any other malignancy. But data
on the prevalence of thyroid malignancy among thyroid enlarged patients were very limited in the study area.
Therefore, this study was aimed to determine the prevalence of thyroid malignancies among thyroid enlarged patients.
Methods: Data of 846 thyroid enlarged patients registered from January 2010 to February 2013 were collected from
fine needle aspirate cytology and histology (for inconclusive and the neoplastic cases) log books. It was entered and
analyzed using SPSS version 20. Odds ratio was calculated to assess the presence and strength of association between
the outcome variable and the explanatory variables. P-values less than 0.05 were considered statistically significant.
Results: Among the 846 thyroid enlarged patients, 62(7.3%) were confirmed to have malignancy. Among malignancies
papillary thyroid carcinoma was the leading, 28 (45.2%), followed by follicular thyroid carcinoma, 18 (29%), and the least
type of thyroid malignancies were medullary thyroid carcinoma and hurtle cell carcinoma, each accounts 1 (1.6%).
Severe form of thyroid malignancy, undifferentiated thyroid carcinoma, was also accounted significant proportion,
12.9%. Older patients having an age of greater than 60 years and patients with solitary thyroid enlargement were more
affected by malignancy compared to the reference age group, 11–20 years and diffused type of enlargement
respectively (AOR: 10.96 (3.15-38.1; AOR: 8.82 (3.49-22.32) respectively).
Conclusions: The prevalence of thyroid malignancy was significantly high and the leading type of malignancy was
papillary thyroid carcinoma followed by follicular thyroid carcinoma. Thyroid malignancy was found to have statistically
significant association with type of enlargement and age.
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Worldwide, the overall prevalence of thyroid malignancy
is approximately 1–5% of all cancers in women and less
than 2% in men. During the past several decades, an in-
creasing incidence of thyroid cancer has been reported
in European countries [1-3], USA [4] and Canada [5]. It* Correspondence: 0923tadie@gmail.com
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unless otherwise stated.is now the fastest growing cancer type and the sixth
most common cancer [1,3,6].
In Europe alone, thyroid malignancy affects approxi-
mately 24,826 individuals annually, with an estimated
mortality rate of 5,993 patients each year [7]. It is also one
of the thyroid diseases problems in sub Saharan Africa
due to high prevalence of iodine deficiency goiter. For
instance, the iodine deficiency is suggested to play a role
for follicular cancer increment in South Africa [8]. It is the
cause of significant mortality and morbidity of patients,
particularly from undifferentiated thyroid carcinoma.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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may also occur unless early diagnosis and treatment is ini-
tiated [9].
To design and implement cost effective and appropri-
ate intervention, knowledge on local prevalence and dis-
tribution of thyroid malignancies among thyroid
enlarged patients have paramount importance. In the
study area there is scarcity of information on prevalence
and type of thyroid malignancies. Hence, this study is
aimed to determine the prevalence and types of thyroid
malignancies among thyroid enlarged patients in Gon-
dar, Northwest Ethiopia.
Methods
Institutional based retrospective study was conducted
among 846 thyroid enlarged patients registered at Gondar
University referral Hospital (GUH) from January 2010 to
February 2013. The Hospital is located in Gondar town
which is the capital city of North Gondar administrative
zone of Amhara regional state, Ethiopia. The Hospital
serves a population of around five million across Amhara
region and adjacent regions. In the hospital conventional
fine needle aspirate cytology (FNAC) technique without
any ultrasound guidance has been used for the assessment
of thyroid enlargement. Usage of ultrasound is unusual to
suggest thyroid malignancy except in case of thyroid cyst.
Demographic information of patients, clinical features,
FNAC and tissue biopsy results were extracted from
FNAC and tissue biopsies log book of Pathology depart-
ment using data abstraction sheet. For the current study,
FNAC results were categorized under 4 groups. When
FNAC results had reported as “papillary thyroid carcin-
oma (PTC)”, “medullary thyroid carcinoma (MTC)”,
“undifferentiated carcinoma”, “lymphoma” or “metastatic
tumor”, the author categorized under malignant group.
The authors also classified them as neoplasm lesion if
the reports had been “neoplasm” or “suggestive for neo-
plasm”. Likewise, if the reports had been “colloid goiter”,
“thyroid cyst” and “thyroiditis”, it was reported as benign
(non-neoplastic). Moreover, if it had reported as “non
diagnostic” or “suggestive for malignancy”, the author
classified them as inconclusive FNAC result. The neo-
plasm and the inconclusive FNAC results were con-
firmed by the tissue biopsy findings.
The size and type of enlargements were determined
previously by physicians. The size had been assessed
based on the measurement of the enlargements by meter
in a two dimensional fashion and the diameter of the en-
largement was estimated from the area of the enlarge-
ment. The type of enlargement was classified as diffuse:
if the most part of the gland enlarged in a consistent
manner, multi-nodular: if there was more than one nod-
ule by clinical palpation, and solitary if there was a single
nodule in either of the thyroid lobules.Data were entered and analyzed using SPSS version
20. Descriptive statistical analyses were done to give a
clear picture of background variables like age, sex and
clinical data. Odds ratio was calculated to assess the
presence and strength of association between outcome
variable and explanatory variables. Ethical approval was
obtained from Research and Ethics Committee of School
of Biomedical and Laboratory Sciences. Confidentiality
was maintained while collecting data using codes.
Results
Among a total of 846 thyroid enlarged patients 661
(78.1%) were females and 185 (21.9 %) were males with
male to female ratio of 1:3.6. The mean age at diagnosis
was 29.7 year for males (ranges from2-78 years SD; 16.5)
and 30.8 year for females (ranges from 5–80 years; SD:
14). Majority of the study participants were at the age of
21–30 years 257/846 (30.4%) followed by 11–20 years of
age, 238/846 (28.1%).
The types of thyroid enlargements observed in this
study were multi nodular goiter (MNG), diffuse and soli-
tary with a proportion of 59.3%, 29% and 11.7% respect-
ively. The duration of enlargement found to be long in
most of the study participants. The mean duration and
enlargement diameter at the time of diagnosis were
5.32 years (range from 1 week to 50 years) and 6.1 cm
(ranges between1.13 cm −19.54 cm) respectively. Most
of study participants (96.9%) had a thyroid enlargement
of 3.5 cm diameter and more, in size.
In this study, the prevalence of thyroid malignancy was
7.3% (62/846). Result from FNAC demonstrated thyroid
malignancies among 34 cases, follicular and hurtle cell
neoplasms among 54 cases, inconclusive for malignancies
among12 cases and the remaining 759 were nodular col-
loid goiters thyroid cysts and thyroiditis. Of the 54 follicu-
lar neoplasms diagnosed by FNAC, 19 (35.2%) cases were
malignant, while among 12 cases with an inconclusive
FNAC report, 9(75%) revealed malignant cancer on the
final histopathological examination.
The leading type of malignancy was PTC 28/62
(45.2%) followed by follicular thyroid carcinoma (FTC)
18/62 (29%). and the least type of thyroid malignancies
were MTC and hurthle cell carcinoma (HCC), each ac-
counts 1/62 (1.6%). Hurtle cell carcinoma and MTC
were the least type of thyroid malignancy which were
found in a 55 years old female and in a 35 years old male
respectively (Figure 1). Undifferentiated carcinoma had
accounts significant proportion, 12.9%. Metastasis can-
cer to thyroid was also found in four patients, two of
them were originated from the oropharyngeal area and
the remaining spindle cell carcinomas were from un-
known source.
Sex, duration of enlargement and enlargement size
didn’t show statistically significant association with thyroid
Undifferenti
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Figure 1 Type of thyroid malignancies at pathology laboratory of
GUH from 2010–2012. From a total of 62 malignant cases papillary
carcinoma (PTC) accounts highest 28/62 (45.2%) followed by follicular
carcinoma (FTC) 18/62 (29%). Medullary thyroid carcinoma (MTC) and
hurthle cell carcinoma (HCC) accounts one (1.6%).
Table 1 Prevalence of tyroid malignancy at pathology labora
Variable Non malignant N (
Sex Male 171(92.4)
Female 613(92.7)
Age in years 0-10 22(95.7)
11-20 231(97.1)
21-30 236(91.8)
31-40 133(91.7)
41-50 91(91)
51-60 48(88.9)
>60 23(79.3)
Size in cm 0-1.49 6(100)
1.5-1.99 3(100)
2-2.49 9(90.0)
3-3.5 6(85.7)
>3.5 760(92.7)
Duration of enlargement in year <0.6 years 58(93.5)
0.6-1 year 115(85.8)
2-5 years 365(93.1)
6-10 years 160(94.7)
11-15 years 36(97.3)
>15 years 50(96.2)
Type of enlargement Solitary 78(78.8)
MNG 468(93.2)
Diffuse 238(97.1)
COR: Crude Odds Ratio, AOR: Adjusted Odds Ratio.
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shown statistically significant association with thyroid ma-
lignancy. Older patients having an age of greater than
60 years and patients with solitary thyroid enlargement
were more affected by malignancy compared to the ref-
erence age group, 11–20 years and diffused type of en-
largement respectively (AOR: 10.96 (3.15-38.1; AOR:
8.82 (3.49-22.32) respectively) (Table 1).
Discussion
In this study relatively lower prevalence of thyroid ma-
lignancy (TM) was observed, 7.3% (62/846). In contrast
to this many report from United Kingdom (18.3%) [10],
Romania (15.5%) [11], Ethiopia (11.5%) [12] and Pakistan
(11%) [13] showed a little bit higher prevalence of TM.
This may be due to the variations of the study design
and sample size. Most of the above studies used only tis-
sue biopsy sample which have greater sensitivity than
FNAC thereby it may increase the prevalence of thyroid
carcinoma.
The prevalence of TM among MNG (34/502, 6.8%)
was lower than a study conducted in India (10%) [14]
and Italy (13.7%) [15] where as among solitary nodule,tory of GUH from 2010–2013
%) Malignant N (%) COR (95% CI) AOR (95% CI)
14(7.6) 1.05(0.56-1.94)
48(7.3) 1
1(4.3) 1.5(0.18-12.76) 1.31(.156-11.78)
7(2.9) 1
21(8.2) 2.94(1.23-7.04) 2.94(1.19-7.2)
12(8.3) 2.98(1.14-7.75) 2.68(0.99-7.22)
9(9) 3.26(1.18-9.03) 3.26(1.14-9.33)
6(11.1) 4.13(1.33-12.82) 4.97(1.51-16.33)
6(20.7) 8.61(2.67-27.78) 10.96(3.15-38.1)
0
0
1(10) 1.41(0.18-11.3) 02.87(0.22-15.98)
1(14.3) 2.11(0.25-17.83) 2.36(0.236-23.70)
60(7.3) 1 1
4(6.5) 2.48(0.27-23.1)
19(14.2) 5.95(0.77-46.0)
27(6.9) 2.66(0.35-2018)
9 (5.3) 2.03(0.25-16.50)
1(2.7) 1
2(3.8) 1.44(0.13-16.50)
21(21.2) 9.154(3.75-22.35) 8.82(3.49-22.32)
34(6.8) 2.47(1.08-5.66) 2.52(1.07-5.93)
7(2.9) 1 1
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higher than a study conducted in Pakistan (12.76%) and
Sudan (13.5%). This may be due to the fact that 50% of
solitary nodules found on palpation are actually part of
multi-nodular goitre [16,17].
This study depicted that PTC accounts the highest
proportion of thyroid malignancies 28/62, (45.2%). In
line with this finding, the leading type of thyroid malig-
nancy that has been documented in different studies was
PTC followed by follicular carcinoma [11,18-20].
Follicular carcinoma was the second common type of
thyroid malignancy in this study (29%). This is almost
consistent with the finding obtained from Rawalpindi,
Pakistan (25%) [14]. But different studies indicated that
the proportions of FTC is in between 10-20% [18,14].
This high proportion is probably due to high incidence of
iodine deficiency goiter in the study area [21]. Hence iod-
ine deficiency goiter is suggested to cause follicular carcin-
oma [8]. Hurthle cell carcinoma, which is a subtype of
follicular carcinoma, also diagnosed in one (1.6%) patient
having the age of 55 years. In line with this finding other
study done in Romania also reported that HCC accounts
1.6% of the total type of TM [13] and the diseases is more
likely occur in older patients [22].
Lymphoma was also found in 2/62, (3%) of the elderly
female patients (>60 year) in this study. This finding is
consistent with reports from other studies which re-
ported primary lymphoma of the thyroid gland among
old age (>50 years) females [23-25].
Due to the fact that data were taken in retrospective
manner, the authors couldn’t determine the risk factors
as well as associated clinical feature for thyroid malig-
nancy like thyroid functions. Moreover, since data were
collected from convenient FNAC technique (by exclud-
ing for neoplasm cases and inconclusive FNAC results),
it may affect the result generated from this study. Tu-
mors haven’t also staged according to its size, node me-
tastasis and distance metastasis and this limits the
information of this study. Future research with detail
socio demographic information and clinical feature is
crucial to determine the associated risk factors and clin-
ical feature for thyroid malignancy.
Conclusion
Prevalence of thyroid malignancy was lower than reports
from other study areas but still considered significant
and the leading type of malignancy was PTC followed by
FTC. Thyroid malignancy has an association with type
of enlargement and age of the patient.
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